1477 Results

People

  1. Motzer
    Motzer
  2. Hudis
    Hudis
  3. Aghajanian
    Aghajanian
  4. O'Reilly
    O'Reilly
  5. Kris
    Kris
  6. Scher
    Scher
  7. Panageas
    Panageas
  8. Saltz
    Saltz
  9. Schwartz
    Schwartz
  10. Kelsen
    Kelsen

Groups

  1. Department of Medicine (1039)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (287)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (216)
  6. Genitourinary Oncology Service (208)
  7. Epidemiology and Biostatistics (194)
  8. Biostatistics Service (169)
  9. Gastrointestinal Oncology Service (160)
  10. Population Sciences Research Program (158)
  1. "fatigue"
Formats
  1. Journal Article (1402)
  2. Review (38)
  3. Research Letter (13)
  4. Editorial (10)
  5. Conference Paper (5)
  6. Guidelines (4)
  7. Correspondence (3)
  8. Book Section (2)
Groups
  1. Department of Medicine (1039)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (287)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (216)
  6. Genitourinary Oncology Service (208)

More Groups

People
  1. Robert Motzer (85)
  2. Clifford Hudis (49)
  3. Carol Aghajanian (46)
  4. Eileen O'Reilly (46)
  5. Howard Scher (44)
  6. Mark Kris (44)

More People

Years
  1. 2025 (60)
  2. 2024 (132)
  3. 2023 (89)
  4. 2022 (46)
  5. 2021 (33)
  6. 2020 (85)

More Years

Publications
  1. Journal of Clinical Oncology (108)
  2. Clinical Cancer Research (82)
  3. Cancer (63)
  4. Lancet Oncology (50)
  5. Gynecologic Oncology (41)
  6. Annals of Oncology (37)

More Publications

Publishers
  1. Elsevier Inc. (244)
  2. Springer (133)
  3. American Society of Clinical Oncology (114)
  4. Elsevier Science, Inc. (108)
  5. Oxford University Press (101)
  6. American Association for Cancer Research (89)

More Publishers

Results (1477)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature T-cell lymphoma
    Journal Article

    Ryu Tiger, Y. K.; Jain, S.; Barta, S. K.; Tolu, S.; Estrella, B.; Sawas, A.; Lue, J. K.; Francescone, M. M.; Pro, B.; Amengual, J. E.
    Leukemia and Lymphoma (2024)

    Fulltext@MSK | Save
  • Stereotactic body radiation therapy for stage IIA to IIIA inoperable non-small cell lung cancer: A phase 1 dose-escalation trial
    Journal Article

    Rimner, A.; Gelblum, D. Y.; Wu, A. J.; Shepherd, A. F.; Mueller, B.; Zhang, S.; Cuaron, J.; Shaverdian, N.; Flynn, J.; Fiasconaro, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • A whole food, plant-based randomized controlled trial in metastatic breast cancer: feasibility, nutrient, and patient-reported outcomes
    Journal Article

    Campbell, E. K.; Campbell, T. M.; Culakova, E.; Blanchard, L.; Wixom, N.; Guido, J. J.; Fetten, J.; Huston, A.; Shayne, M.; Janelsins, M. C.; more...
    Breast Cancer Research and Treatment (2024)

    Fulltext@MSK | Save
  • Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study
    Journal Article

    Nooka, A. K.; Kaufman, J. L.; Rodriguez, C.; Jakubowiak, A.; Efebera, Y.; Reeves, B.; Wildes, T. M.; Holstein, S. A.; Anderson, L. D. Jr; Badros, A.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient-reported outcomes from GRIFFIN
    Journal Article

    Silbermann, R.; Laubach, J.; Kaufman, J. L.; Sborov, D. W.; Reeves, B.; Rodriguez, C.; Chari, A.; Costa, L. J.; Anderson, L. D. Jr; Nathwani, N.; more...
    American Journal of Hematology (2024)

    Fulltext@MSK | Save
  • Larotrectinib treatment for patients with TRK fusion-positive salivary gland cancers
    Journal Article

    Le, X.; Baik, C.; Bauman, J.; Gilbert, J.; Brose, M. S.; Grilley-Olson, J. E.; Patil, T.; McDermott, R.; Raez, L. E.; Johnson, J. M.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Bladder cancer survivors who do not smoke have better longitudinal health-related quality of life measures: An assessment of the Comparative Effectiveness and Survivorship Health in Bladder Cancer (CEASE-BC) study
    Journal Article

    Kay, H.; Silver, S. N.; Smith, A. B.; Basak, R.; Shoenbill, K.; Usinger, D.; Goldstein, A. O.; Matulewicz, R. S.; Chen, R.; Bjurlin, M. A.
    Journal of Urology (2024)

    Fulltext@MSK | Save
  • Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
    Journal Article

    Makker, V.; Perez-Fidalgo, J. A.; Valabrega, G.; Hamilton, E.; Van Gorp, T.; Sehouli, J.; Regináčová, K.; Richardson, D. L.; Perri, T.; Oza, A. M.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
    Journal Article

    Valabrega, G.; Pothuri, B.; Oaknin, A.; Graybill, W. S.; Sánchez, A. B.; McCormick, C.; Baurain, J. F.; Tinker, A. V.; Denys, H.; O'Cearbhaill, R. E.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • A plain language summary of the PHAROS study: The combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small-cell lung cancer
    Review

    Riely, G. J.; Smit, E. F.; Ahn, M. J.; Felip, E.; Ramalingam, S. S.; Tsao, A.; Johnson, M.; Gelsomino, F.; Esper, R.; Nadal, E.; more...
    Future Oncology (2024)

    Fulltext@MSK | Save